 | • レポートコード：D0FB0646455 • 出版社/出版日：Prof Research / 2019年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：製薬・医療 |
| Single User | ￥420,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥532,000 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥700,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 慢性閉塞性肺疾患薬のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は慢性閉塞性肺疾患薬の市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおける慢性閉塞性肺疾患薬市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。 ・市場概要 ・産業チェーン分析（ファイブフォース分析、コスト構造分析） ・市場動向 ・慢性閉塞性肺疾患薬のアジア市場規模推移2014-2019 ・慢性閉塞性肺疾患薬のアジア市場規模予測2019-2024 ・慢性閉塞性肺疾患薬のサプライヤー分析 ・顧客（需要先）分析 ・主要企業分析（AstraZeneca、Boehringer Ingelheim、GSK、Novartis、Teva Pharmaceuticals、Ache Laboratorios Farmaceuticos、Almirall、Aquinox Pharmaceuticals、Ario Pharma、Asmacure、Astellas Pharma、BioMarck Pharmaceuti） ・結論 |
Abstract:
The Asia Pacific Chronic Obstructive Pulmonary Disease Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.
This report is an essential reference for who looks for detailed information on Asia Pacific Chronic Obstructive Pulmonary Disease Drugs market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Chronic Obstructive Pulmonary Disease Drugs market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.
Key Points of this Report:
* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of Chronic Obstructive Pulmonary Disease Drugs
* It describes present situation, historical background and future forecast
* Comprehensive data showing Chronic Obstructive Pulmonary Disease Drugs capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on Chronic Obstructive Pulmonary Disease Drugs manufacturers
* Chronic Obstructive Pulmonary Disease Drugs market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us
The largest vendors of Asia Pacific Chronic Obstructive Pulmonary Disease Drugs market: (At least 12 companies included)
* AstraZeneca
* Boehringer Ingelheim
* GSK
* Novartis
* Teva Pharmaceuticals
* Ache Laboratorios Farmaceuticos
For complete list, please ask for sample pages.
The Chronic Obstructive Pulmonary Disease Drugs market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand
The reports analysis Chronic Obstructive Pulmonary Disease Drugs market in Asia Pacific by products type:
* Type I
* Type II
* Type III
The reports analysis Chronic Obstructive Pulmonary Disease Drugs market in Asia Pacific by application as well:
* Application I
* Application II
* Application III
Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Table of Contents
Chapter One Chronic Obstructive Pulmonary Disease Drugs Overview
1.1 Chronic Obstructive Pulmonary Disease Drugs Outline
1.2 Classification and Application
1.3 Manufacturing Technology
Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis
Chapter Three Market Dynamics of Chronic Obstructive Pulmonary Disease Drugs Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges
Chapter Four Asia Pacific Market of Chronic Obstructive Pulmonary Disease Drugs (2014-2019)
4.1 Chronic Obstructive Pulmonary Disease Drugs Supply
4.2 Chronic Obstructive Pulmonary Disease Drugs Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis
Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 Chronic Obstructive Pulmonary Disease Drugs Supply
5.2 Chronic Obstructive Pulmonary Disease Drugs Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis
Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation
Chapter Seven Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis
Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 AstraZeneca
8.2 Boehringer Ingelheim
8.3 GSK
8.4 Novartis
8.5 Teva Pharmaceuticals
……
……
Chapter Nine Research Conclusions of Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Industry
Tables and Figures
Figure Commercial Product of Chronic Obstructive Pulmonary Disease Drugs
Table Classification of Chronic Obstructive Pulmonary Disease Drugs
Table Application of Chronic Obstructive Pulmonary Disease Drugs
Figure Porter Five Forces Model Analysis of Asia Pacific Chronic Obstructive Pulmonary Disease Drugs
Figure Production Cost Analysis of Asia Pacific Chronic Obstructive Pulmonary Disease Drugs
Table Chronic Obstructive Pulmonary Disease Drugs Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Capacity List
Table 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Production List
Table 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Production Value and Growth Rate
Table 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of Chronic Obstructive Pulmonary Disease Drugs
Table 2014-2019 Asia Pacific Import and Export of Chronic Obstructive Pulmonary Disease Drugs
Table 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Demand List by Application
Figure 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Demand by Application
Table 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Demand Share List by Application
Figure 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Demand Share by Application
Table 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Country-wise Consumption List
Figure 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Country-wise Consumption
Table 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Country-wise Consumption Share
Table 2014-2019 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Capacity List
Table 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Production List
Table 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of Chronic Obstructive Pulmonary Disease Drugs
Table 2019-2024 Asia Pacific Import and Export of Chronic Obstructive Pulmonary Disease Drugs
Table 2019-2024 Asia Pacific Demand of Chronic Obstructive Pulmonary Disease Drugs by Application
Figure 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Demand by Application
Table 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Demand Share List by Application
Figure 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Demand Share by Application
Table 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Country-wise Consumption List
Figure 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Country-wise Consumption
Table 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Country-wise Consumption Share
Table 2019-2024 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Raw Material Suppliers
Table Key End Users List
Table Profile of AstraZeneca
Table SWOT Analysis of AstraZeneca
Table AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Product Specification
Table 2014-2019 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Capacity Production and Growth Rate
Figure 2014-2019 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Production Global Market Share
Table SWOT Analysis of Boehringer Ingelheim
Figure Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Products
Table 2014-2019 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Capacity Production and Growth Rate
Figure 2014-2019 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Production Global Market Share
Table SWOT Analysis of GSK
Figure GSK Chronic Obstructive Pulmonary Disease Drugs Product
Table GSK Chronic Obstructive Pulmonary Disease Drugs Product Specification
Table 2014-2019 GSK Chronic Obstructive Pulmonary Disease Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 GSK Chronic Obstructive Pulmonary Disease Drugs Capacity Production and Growth Rate
Figure 2014-2019 GSK Chronic Obstructive Pulmonary Disease Drugs Production Global Market Share
Table Profile of Novartis
Table SWOT Analysis of Novartis
Figure Novartis Chronic Obstructive Pulmonary Disease Drugs Product
Table Novartis Chronic Obstructive Pulmonary Disease Drugs Product Specification
Table 2014-2019 Novartis Chronic Obstructive Pulmonary Disease Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Novartis Chronic Obstructive Pulmonary Disease Drugs Capacity Production and Growth Rate
Figure 2014-2019 Novartis Chronic Obstructive Pulmonary Disease Drugs Production Global Market Share
Table Profile of Teva Pharmaceuticals
Table SWOT Analysis of Teva Pharmaceuticals
Figure Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Product
Table 2014-2019 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Capacity Production and Growth Rate
Figure 2014-2019 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Production Global Market Share
……
……
慢性閉塞性肺疾患のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Chronic Obstructive Pulmonary Disease market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detaile…- 慢性閉塞性肺疾患治療のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Chronic Obstructive Pulmonary Disease Treatment market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks f…
- 慢性閉塞性肺疾患（COPD）装置のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Devices market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who lo…
- 慢性閉塞性肺疾患（COPD）のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Chronic Obstructive Pulmonary Disorder (COPD) market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for…
- 慢性血栓塞栓性肺高血圧症のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Chronic Thromboembolic Pulmonary Hypertension market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for…